These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27859025)

  • 1. Modeling Drug-Induced Neuropathy Using Human iPSCs for Predictive Toxicology.
    Ohara R; Imamura K; Morii F; Egawa N; Tsukita K; Enami T; Shibukawa R; Mizuno T; Nakagawa M; Inoue H
    Clin Pharmacol Ther; 2017 Jun; 101(6):754-762. PubMed ID: 27859025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotenone exerts developmental neurotoxicity in a human brain spheroid model.
    Pamies D; Block K; Lau P; Gribaldo L; Pardo CA; Barreras P; Smirnova L; Wiersma D; Zhao L; Harris G; Hartung T; Hogberg HT
    Toxicol Appl Pharmacol; 2018 Sep; 354():101-114. PubMed ID: 29428530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of induced pluripotent stem cells as a translational model for neurotoxicological risk.
    Kumar KK; Aboud AA; Bowman AB
    Neurotoxicology; 2012 Jun; 33(3):518-29. PubMed ID: 22330734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cell-derived motor neurons of CMT type 2 patients reveal progressive mitochondrial dysfunction.
    Van Lent J; Verstraelen P; Asselbergh B; Adriaenssens E; Mateiu L; Verbist C; De Winter V; Eggermont K; Van Den Bosch L; De Vos WH; Timmerman V
    Brain; 2021 Sep; 144(8):2471-2485. PubMed ID: 34128983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards in vitro DT/DNT testing: Assaying chemical susceptibility in early differentiating NT2 cells.
    Menzner AK; Abolpour Mofrad S; Friedrich O; Gilbert DF
    Toxicology; 2015 Dec; 338():69-76. PubMed ID: 26498558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of induced pluripotent stem cell (iPSC) line from a 36-year-old Charcot-Marie-Tooth disease patient with GJB1 mutation (CMTX).
    Son D; Kang PJ; Yun W; You S
    Stem Cell Res; 2017 May; 21():9-12. PubMed ID: 28677541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energy metabolism and mitochondrial defects in X-linked Charcot-Marie-Tooth (CMTX6) iPSC-derived motor neurons with the p.R158H PDK3 mutation.
    Perez-Siles G; Cutrupi A; Ellis M; Screnci R; Mao D; Uesugi M; Yiu EM; Ryan MM; Choi BO; Nicholson G; Kennerson ML
    Sci Rep; 2020 Jun; 10(1):9262. PubMed ID: 32504000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage-specific metabolic features of differentiating neurons: Implications for toxicant sensitivity.
    Delp J; Gutbier S; Cerff M; Zasada C; Niedenführ S; Zhao L; Smirnova L; Hartung T; Borlinghaus H; Schreiber F; Bergemann J; Gätgens J; Beyss M; Azzouzi S; Waldmann T; Kempa S; Nöh K; Leist M
    Toxicol Appl Pharmacol; 2018 Sep; 354():64-80. PubMed ID: 29278688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional and metabolic adaptation of human neurons to the mitochondrial toxicant MPP(+).
    Krug AK; Gutbier S; Zhao L; Pöltl D; Kullmann C; Ivanova V; Förster S; Jagtap S; Meiser J; Leparc G; Schildknecht S; Adam M; Hiller K; Farhan H; Brunner T; Hartung T; Sachinidis A; Leist M
    Cell Death Dis; 2014 May; 5(5):e1222. PubMed ID: 24810058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aged iPSCs display an uncommon mitochondrial appearance and fail to undergo in vitro neurogenesis.
    Masotti A; Celluzzi A; Petrini S; Bertini E; Zanni G; Compagnucci C
    Aging (Albany NY); 2014 Dec; 6(12):1094-108. PubMed ID: 25567319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the pathogenesis of ATP1A1-related CMT disease using patient-specific iPSCs.
    Manganelli F; Parisi S; Nolano M; Miceli F; Tozza S; Pisciotta C; Iodice R; Provitera V; Cicatiello R; Zuchner S; Taglialatela M; Russo T; Santoro L
    J Peripher Nerv Syst; 2019 Dec; 24(4):330-339. PubMed ID: 31707753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities.
    Schmidt BZ; Lehmann M; Gutbier S; Nembo E; Noel S; Smirnova L; Forsby A; Hescheler J; Avci HX; Hartung T; Leist M; Kobolák J; Dinnyés A
    Arch Toxicol; 2017 Jan; 91(1):1-33. PubMed ID: 27492622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods.
    Bal-Price A; Pistollato F; Sachana M; Bopp SK; Munn S; Worth A
    Toxicol Appl Pharmacol; 2018 Sep; 354():7-18. PubMed ID: 29476865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Fluorouracil inhibits neural differentiation via Mfn1/2 reduction in human induced pluripotent stem cells.
    Yamada S; Yamazaki D; Kanda Y
    J Toxicol Sci; 2018; 43(12):727-734. PubMed ID: 30518710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication-induced exacerbation of neuropathy in Charcot Marie Tooth disease.
    Weimer LH; Podwall D
    J Neurol Sci; 2006 Mar; 242(1-2):47-54. PubMed ID: 16386273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Availability of Stem Cell-Based In Vitro Methods for Developmental Neurotoxicity (DNT) Testing.
    Fritsche E; Barenys M; Klose J; Masjosthusmann S; Nimtz L; Schmuck M; Wuttke S; Tigges J
    Toxicol Sci; 2018 Sep; 165(1):21-30. PubMed ID: 29982830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial biogenesis and neural differentiation of human iPSC is modulated by idebenone in a developmental stage-dependent manner.
    Augustyniak J; Lenart J; Zychowicz M; Stepien PP; Buzanska L
    Biogerontology; 2017 Aug; 18(4):665-677. PubMed ID: 28643190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic risk for Parkinson's disease correlates with alterations in neuronal manganese sensitivity between two human subjects.
    Aboud AA; Tidball AM; Kumar KK; Neely MD; Ess KC; Erikson KM; Bowman AB
    Neurotoxicology; 2012 Dec; 33(6):1443-1449. PubMed ID: 23099318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Induced Pluripotent Stem Cell-Derived 3D-Neurospheres are Suitable for Neurotoxicity Screening.
    Kobolak J; Teglasi A; Bellak T; Janstova Z; Molnar K; Zana M; Bock I; Laszlo L; Dinnyes A
    Cells; 2020 May; 9(5):. PubMed ID: 32369990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.